Status:
COMPLETED
Comparison of Visual Field Assessments Between Three Perimeters
Lead Sponsor:
Gainesville Eye Associates
Collaborating Sponsors:
Sengi
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A single center, prospective, randomized, comparative study of visual field assessments between the TEMPO, VisuALL, and HFA perimeters. Subjects will be assessed at 1 visit. Clinical evaluations will ...
Eligibility Criteria
Inclusion
- Adult patients with best-corrected visual outcomes of 20/30 or better.
Exclusion
- Unable to tolerate ophthalmic imaging
- Any ocular or systemic conditions, that could affect VF test results, such as age-related macular degeneration, peripheral retinal disease, or severe glaucoma.
- The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.
Key Trial Info
Start Date :
November 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 12 2025
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06539715
Start Date
November 18 2024
End Date
March 12 2025
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
North Georgia Eye Associates
Gainesville, Georgia, United States, 30501